Initiation of agomelatine after antidepressant treatment in outpatients suffering major depressive disorder.
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Agomelatine (Primary) ; Antidepressants
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors IRIS
- 01 Feb 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 23 Sep 2011 Planned end date changed from 31 Dec 2011 to 31 Jan 2012 as reported by ISRCTN: Current Controlled Trials.
- 17 Sep 2010 New trial record